Elanco Animal Health (NYSE: ELAN) officer disposes shares for tax withholding

Rhea-AI Filing Summary

Elanco Animal Health officer Cabral Ramiro Martin reported a tax-withholding disposition of 6,492 shares of common stock at $24.88 per share on March 3, 2026. After this non-market transaction, he directly owned 283,874 common shares.

Insider Trade Summary

Net Seller: 6,492 shares

Net Sell 1 txn

Insider Cabral Ramiro Martin

Role SEE REMARKS

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	6,492	$24.88	$162K

Holdings After Transaction: Common Stock — 283,874 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/05/2026 - 04:14 PM Learn about SEC filing dates

FAQ

What insider transaction did ELAN officer Cabral Ramiro Martin report?

Cabral Ramiro Martin reported a tax-withholding disposition of Elanco Animal Health common stock. The Form 4 shows this was a code F transaction, meaning shares were delivered to cover tax liabilities rather than sold in an open-market trade.

How many Elanco Animal Health (ELAN) shares were disposed of in this Form 4?

The Form 4 reports a disposition of 6,492 common shares of Elanco Animal Health. These shares were used for tax withholding, classified under transaction code F as payment of tax liability by delivering securities instead of cash.

What price per share was used for the ELAN tax-withholding disposition?

The reported tax-withholding disposition used a price of $24.88 per share for 6,492 Elanco Animal Health common shares. This price is the value used to calculate the tax payment via delivered shares, not necessarily an open-market trade price.

How many Elanco Animal Health shares does Cabral Ramiro Martin own after this transaction?

After the tax-withholding disposition, Cabral Ramiro Martin directly owned 283,874 shares of Elanco Animal Health common stock. The Form 4 lists this amount as the total shares following the transaction under his direct ownership.

Was the ELAN insider transaction a market sale or a tax-withholding event?

The transaction was a tax-withholding disposition, not an open-market sale. It is coded F, described as payment of tax liability by delivering securities, where shares are surrendered to satisfy tax obligations tied to equity compensation.

When did the Elanco Animal Health insider tax-withholding transaction occur?

The Form 4 lists the transaction date as March 3, 2026. On that date, 6,492 Elanco Animal Health common shares were disposed of as a tax-withholding event under transaction code F for Cabral Ramiro Martin’s equity-related tax obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cabral Ramiro Martin

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEE REMARKS

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		F		6,492	D	$24.88	283,874	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Executive Vice President - Elanco International

	/s/ Amy C. Seidel, as Attorney-in-Fact for Ramiro Martin Cabral	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.